Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Hosted content
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 75, Issue 1
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts
PDF
Chest clinic
Case based discussion
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage
Online download statistics by month:
Online download statistics by month: October 2019 to March 2021
Abstract
Full
Pdf
Oct 2019
184
8
1
Nov 2019
678
82
54
Dec 2019
1040
61
41
Jan 2020
909
64
30
Feb 2020
171
30
13
Mar 2020
182
28
21
Apr 2020
102
14
5
May 2020
111
14
8
Jun 2020
113
15
7
Jul 2020
153
11
5
Aug 2020
92
17
8
Sep 2020
98
10
5
Oct 2020
92
11
10
Nov 2020
89
24
19
Dec 2020
114
8
4
Jan 2021
59
11
8
Feb 2021
111
9
5
Mar 2021
85
12
6
Total
4383
429
250
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF